{"id":911587,"date":"2025-11-19T08:42:02","date_gmt":"2025-11-19T13:42:02","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/dexcom-smart-basal-receives-fda-clearance-becoming-the-first-and-only-cgm-integrated-basal-insulin-dosing-optimizer-for-type-2-diabetes\/"},"modified":"2025-11-19T08:42:02","modified_gmt":"2025-11-19T13:42:02","slug":"dexcom-smart-basal-receives-fda-clearance-becoming-the-first-and-only-cgm-integrated-basal-insulin-dosing-optimizer-for-type-2-diabetes","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/dexcom-smart-basal-receives-fda-clearance-becoming-the-first-and-only-cgm-integrated-basal-insulin-dosing-optimizer-for-type-2-diabetes\/","title":{"rendered":"Dexcom Smart Basal Receives FDA Clearance Becoming the First and Only CGM-integrated Basal Insulin Dosing Optimizer for Type 2 Diabetes"},"content":{"rendered":"<p>        <!--.bwalignc { text-align: center; list-style-position: inside }\n.bwlistdisc { list-style-type: disc }\n.bwuline { text-decoration: underline }body {font:normal small Arial,Helvetica,sans-serif;color:#000;background-color:#fff;padding:24px;margin:0;} a img {border:0;} h3 {font-size:medium;color:#000;margin:0 0 1em 0; text-align:center;}-->  <\/p>\n<p class=\"bwalignc\"><b>Dexcom Smart Basal Receives FDA Clearance Becoming the First and Only CGM-integrated Basal Insulin Dosing Optimizer for Type 2 Diabetes<\/b><\/p>\n<ul class=\"bwlistdisc\">\n<li><i>Dexcom Smart Basal is designed to make basal insulin initiation and management simpler and more personalized<sup \/>for users and their healthcare providers.<sup>*<\/sup><\/i><\/li>\n<li><i>Dexcom Smart Basal is FDA cleared and now the first and only CGM-integrated basal insulin dosing optimizer for adults aged 18 and older with Type 2 diabetes who are using long-acting insulin.<sup>1<\/sup><\/i><\/li>\n<\/ul>\n<p>SAN DIEGO&#8211;(<a href=\"http:\/\/www.businesswire.com\">BUSINESS WIRE<\/a>)&#8211;<a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.dexcom.com%2F&amp;esheet=54360576&amp;newsitemid=20251119356019&amp;lan=en-US&amp;anchor=DexCom%2C+Inc.&amp;index=1&amp;md5=e71ff7e6cb69676faaf5639f1b11dbfc\"><b>DexCom, Inc.<\/b><\/a><b> (NASDAQ: DXCM),<\/b> the global leader in glucose biosensing, announced today the FDA has cleared Dexcom Smart Basal, the first and only CGM-integrated basal insulin dosing optimizer designed for adults with Type 2 diabetes on glargine U-100 long-acting insulin therapy.<sup>1<\/sup> Dexcom Smart Basal will use Dexcom G7 15 Day sensor data and logged doses to calculate personalized daily recommendations to guide users towards a more effective long-acting insulin dose, as directed by their healthcare provider.<\/p>\n<p id=\"news-body-cta\">This press release features multimedia. View the full release here: <a href=\"https:\/\/www.businesswire.com\/news\/home\/20251119356019\/en\/\" rel=\"nofollow\">https:\/\/www.businesswire.com\/news\/home\/20251119356019\/en\/<\/a><\/p>\n<div id=\"bwbodyimg\" style=\"width: 329px;float:left;padding-left:0px;padding-right:20px;padding-top:0px;padding-bottom:0px\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20251119356019\/en\/2648806\/4\/Smart_Basal_FDA_Clearance_Image-UI-1.jpg\" alt=\"Dexcom Smart Basal is designed to make basal insulin initiation and management simpler and more personalized for users and their healthcare providers.\" \/><\/p>\n<p style=\"font-size:85%\">Dexcom Smart Basal is designed to make basal insulin initiation and management simpler and more personalized for users and their healthcare providers.<\/p>\n<\/div>\n<p>\n\u201cWe understand that many people with Type 2 diabetes are apprehensive about starting basal insulin due to fears of hypoglycemia and the reality that it often takes months of trial and error to reach the right dose,\u201d said Peter Simpson, senior vice president of innovation and sensor technology at Dexcom. \u201cDexcom Smart Basal is designed to remove barriers to insulin initiation\u2013giving healthcare providers the confidence to start their patients on basal therapy sooner and with greater ease.<sup>1<\/sup> We\u2019re excited about the opportunity to improve this experience for users and their healthcare providers by making it simpler and more personalized.\u201d<\/p>\n<p><b>How Dexcom Smart Basal works:<\/b><\/p>\n<ul class=\"bwlistdisc\">\n<li>\nDexcom Smart Basal begins with an initial basal insulin dose set by a healthcare provider.<\/p>\n<\/li>\n<li>\nUsers will receive daily dose recommendations and reminders in the Dexcom G7 15 Day app.<\/p>\n<\/li>\n<li>\nDexcom Smart Basal looks at all of a user\u2019s CGM readings to adjust their personalized insulin dose recommendation, instead of using a single fasting blood glucose measurement.<\/p>\n<\/li>\n<li>\nIf low glucose events occur, Dexcom Smart Basal lowers the user\u2019s insulin dose recommendation by the amount set by their healthcare provider. Dexcom G7 15 Day also offers customizable low alerts that deliver proactive protection against hypoglycemic events and allow users to treat low glucose in real-time.<sup>1,2<\/sup><\/li>\n<li>\nWhen the user\u2019s glucose is consistently within the set target range, they\u2019ll receive their optimal dose and Dexcom Smart Basal will complete.<\/p>\n<\/li>\n<\/ul>\n<p>\nDexcom Smart Basal will be added to the Dexcom G7 15 Day experience shortly after the product launches in the United States. Once Dexcom Smart Basal is available, healthcare providers can seamlessly integrate it into their workstreams by prescribing and configuring the system using Dexcom Clarity, saving time and simplifying care for patients.<\/p>\n<p>\nEfforts are underway to bring Dexcom Smart Basal to international markets in the future.<\/p>\n<p><b><span class=\"bwuline\">About Dexcom<\/span><\/b><\/p>\n<p>\nDexcom empowers people to take control of health through innovative biosensing technology. Founded in 1999, Dexcom has pioneered and set the standard in glucose biosensing for more than 25 years. Its technology has transformed how people manage diabetes and track their glucose, helping them feel more in control and live more confidently.<\/p>\n<p>\nDexcom. Discover what you\u2019re made of. For more information, visit <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.dexcom.com%2F&amp;esheet=54360576&amp;newsitemid=20251119356019&amp;lan=en-US&amp;anchor=www.dexcom.com&amp;index=2&amp;md5=7a494da273fa44a0e89fca2c3600315d\">www.dexcom.com<\/a>.<\/p>\n<p><i>Category: IR<\/i><\/p>\n<p><i>*When compared to SMBG and a single fasting blood glucose measurement. 1 Dexcom, data on file, 2025. 2 Dexcom G7 15 Day User Guide.<\/i><\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20251119356019r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" style=\"width:0;height:0\" \/><span class=\"bwct31415\" \/><\/p>\n<p id=\"mmgallerylink\"><span id=\"mmgallerylink-phrase\">View source version on businesswire.com: <\/span><span id=\"mmgallerylink-link\"><a href=\"https:\/\/www.businesswire.com\/news\/home\/20251119356019\/en\/\" rel=\"nofollow\">https:\/\/www.businesswire.com\/news\/home\/20251119356019\/en\/<\/a><\/span><\/p>\n<p><b><span class=\"bwuline\">Media Contact<br \/>\n<\/span><\/b><br \/>Aly Brandt<br \/>\n<br \/><a rel=\"nofollow\" href=\"mailto:mediarelations@dexcom.com\">mediarelations@dexcom.com<\/a><\/p>\n<p><b><span class=\"bwuline\">Investor Contact<br \/>\n<\/span><\/b><br \/>Sean Christensen<br \/>\n<br \/><a rel=\"nofollow\" href=\"mailto:sean.christensen@dexcom.com\">sean.christensen@dexcom.com<\/a><\/p>\n<p><b>KEYWORDS:<\/b> California United States North America<\/p>\n<p><b>INDUSTRY KEYWORDS:<\/b> General Health Diabetes Medical Devices Health Health Technology<\/p>\n<p><b>MEDIA:<\/b><\/p>\n<table cellpadding=\"3\" cellspacing=\"3\">\n<tr>\n<td><font face=\"Arial\" size=\"2\"><b>Photo<\/b><\/font><\/td>\n<\/tr>\n<tr>\n<td><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20251119356019\/en\/2648806\/3\/Smart_Basal_FDA_Clearance_Image-UI-1.jpg\" alt=\"Photo\" \/><\/td>\n<\/tr>\n<tr>\n<td><font face=\"Arial\" size=\"2\">Dexcom Smart Basal is designed to make basal insulin initiation and management simpler and more personalized for users and their healthcare providers.<\/font><\/td>\n<\/tr>\n<tr>\n<td><font face=\"Arial\" size=\"2\"><b>Photo<\/b><\/font><\/td>\n<\/tr>\n<tr>\n<td><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20251119356019\/en\/2648807\/3\/Smart_Basal_FDA_Clearance_Image-UI-2.jpg\" alt=\"Photo\" \/><\/td>\n<\/tr>\n<tr>\n<td><font face=\"Arial\" size=\"2\">Dexcom Smart Basal is FDA cleared and now the first and only CGM-integrated basal insulin dosing optimizer for adults aged 18 and older with Type 2 diabetes who are using long-acting insulin.<\/font><\/td>\n<\/tr>\n<tr>\n<td><font face=\"Arial\" size=\"2\"><b>Logo<\/b><\/font><\/td>\n<\/tr>\n<tr>\n<td><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20251119356019\/en\/1474219\/3\/New_Dexcom_Logo.jpg\" alt=\"Logo\" \/><\/td>\n<\/tr>\n<tr>\n<td><font face=\"Arial\" size=\"2\"><\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"<p>Dexcom Smart Basal Receives FDA Clearance Becoming the First and Only CGM-integrated Basal Insulin Dosing Optimizer for Type 2 Diabetes Dexcom Smart Basal is designed to make basal insulin initiation and management simpler and more personalizedfor users and their healthcare providers.* Dexcom Smart Basal is FDA cleared and now the first and only CGM-integrated basal insulin dosing optimizer for adults aged 18 and older with Type 2 diabetes who are using long-acting insulin.1 SAN DIEGO&#8211;(BUSINESS WIRE)&#8211;DexCom, Inc. (NASDAQ: DXCM), the global leader in glucose biosensing, announced today the FDA has cleared Dexcom Smart Basal, the first and only CGM-integrated basal insulin dosing optimizer designed for adults with Type 2 diabetes on glargine U-100 long-acting insulin therapy.1 Dexcom Smart Basal will &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/dexcom-smart-basal-receives-fda-clearance-becoming-the-first-and-only-cgm-integrated-basal-insulin-dosing-optimizer-for-type-2-diabetes\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Dexcom Smart Basal Receives FDA Clearance Becoming the First and Only CGM-integrated Basal Insulin Dosing Optimizer for Type 2 Diabetes&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-911587","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Dexcom Smart Basal Receives FDA Clearance Becoming the First and Only CGM-integrated Basal Insulin Dosing Optimizer for Type 2 Diabetes - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/dexcom-smart-basal-receives-fda-clearance-becoming-the-first-and-only-cgm-integrated-basal-insulin-dosing-optimizer-for-type-2-diabetes\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Dexcom Smart Basal Receives FDA Clearance Becoming the First and Only CGM-integrated Basal Insulin Dosing Optimizer for Type 2 Diabetes - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Dexcom Smart Basal Receives FDA Clearance Becoming the First and Only CGM-integrated Basal Insulin Dosing Optimizer for Type 2 Diabetes Dexcom Smart Basal is designed to make basal insulin initiation and management simpler and more personalizedfor users and their healthcare providers.* Dexcom Smart Basal is FDA cleared and now the first and only CGM-integrated basal insulin dosing optimizer for adults aged 18 and older with Type 2 diabetes who are using long-acting insulin.1 SAN DIEGO&#8211;(BUSINESS WIRE)&#8211;DexCom, Inc. (NASDAQ: DXCM), the global leader in glucose biosensing, announced today the FDA has cleared Dexcom Smart Basal, the first and only CGM-integrated basal insulin dosing optimizer designed for adults with Type 2 diabetes on glargine U-100 long-acting insulin therapy.1 Dexcom Smart Basal will &hellip; Continue reading &quot;Dexcom Smart Basal Receives FDA Clearance Becoming the First and Only CGM-integrated Basal Insulin Dosing Optimizer for Type 2 Diabetes&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/dexcom-smart-basal-receives-fda-clearance-becoming-the-first-and-only-cgm-integrated-basal-insulin-dosing-optimizer-for-type-2-diabetes\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-11-19T13:42:02+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20251119356019\/en\/2648806\/4\/Smart_Basal_FDA_Clearance_Image-UI-1.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dexcom-smart-basal-receives-fda-clearance-becoming-the-first-and-only-cgm-integrated-basal-insulin-dosing-optimizer-for-type-2-diabetes\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dexcom-smart-basal-receives-fda-clearance-becoming-the-first-and-only-cgm-integrated-basal-insulin-dosing-optimizer-for-type-2-diabetes\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Dexcom Smart Basal Receives FDA Clearance Becoming the First and Only CGM-integrated Basal Insulin Dosing Optimizer for Type 2 Diabetes\",\"datePublished\":\"2025-11-19T13:42:02+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dexcom-smart-basal-receives-fda-clearance-becoming-the-first-and-only-cgm-integrated-basal-insulin-dosing-optimizer-for-type-2-diabetes\\\/\"},\"wordCount\":694,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dexcom-smart-basal-receives-fda-clearance-becoming-the-first-and-only-cgm-integrated-basal-insulin-dosing-optimizer-for-type-2-diabetes\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20251119356019\\\/en\\\/2648806\\\/4\\\/Smart_Basal_FDA_Clearance_Image-UI-1.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dexcom-smart-basal-receives-fda-clearance-becoming-the-first-and-only-cgm-integrated-basal-insulin-dosing-optimizer-for-type-2-diabetes\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dexcom-smart-basal-receives-fda-clearance-becoming-the-first-and-only-cgm-integrated-basal-insulin-dosing-optimizer-for-type-2-diabetes\\\/\",\"name\":\"Dexcom Smart Basal Receives FDA Clearance Becoming the First and Only CGM-integrated Basal Insulin Dosing Optimizer for Type 2 Diabetes - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dexcom-smart-basal-receives-fda-clearance-becoming-the-first-and-only-cgm-integrated-basal-insulin-dosing-optimizer-for-type-2-diabetes\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dexcom-smart-basal-receives-fda-clearance-becoming-the-first-and-only-cgm-integrated-basal-insulin-dosing-optimizer-for-type-2-diabetes\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20251119356019\\\/en\\\/2648806\\\/4\\\/Smart_Basal_FDA_Clearance_Image-UI-1.jpg\",\"datePublished\":\"2025-11-19T13:42:02+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dexcom-smart-basal-receives-fda-clearance-becoming-the-first-and-only-cgm-integrated-basal-insulin-dosing-optimizer-for-type-2-diabetes\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dexcom-smart-basal-receives-fda-clearance-becoming-the-first-and-only-cgm-integrated-basal-insulin-dosing-optimizer-for-type-2-diabetes\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dexcom-smart-basal-receives-fda-clearance-becoming-the-first-and-only-cgm-integrated-basal-insulin-dosing-optimizer-for-type-2-diabetes\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20251119356019\\\/en\\\/2648806\\\/4\\\/Smart_Basal_FDA_Clearance_Image-UI-1.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20251119356019\\\/en\\\/2648806\\\/4\\\/Smart_Basal_FDA_Clearance_Image-UI-1.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dexcom-smart-basal-receives-fda-clearance-becoming-the-first-and-only-cgm-integrated-basal-insulin-dosing-optimizer-for-type-2-diabetes\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Dexcom Smart Basal Receives FDA Clearance Becoming the First and Only CGM-integrated Basal Insulin Dosing Optimizer for Type 2 Diabetes\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Dexcom Smart Basal Receives FDA Clearance Becoming the First and Only CGM-integrated Basal Insulin Dosing Optimizer for Type 2 Diabetes - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/dexcom-smart-basal-receives-fda-clearance-becoming-the-first-and-only-cgm-integrated-basal-insulin-dosing-optimizer-for-type-2-diabetes\/","og_locale":"en_US","og_type":"article","og_title":"Dexcom Smart Basal Receives FDA Clearance Becoming the First and Only CGM-integrated Basal Insulin Dosing Optimizer for Type 2 Diabetes - Market Newsdesk","og_description":"Dexcom Smart Basal Receives FDA Clearance Becoming the First and Only CGM-integrated Basal Insulin Dosing Optimizer for Type 2 Diabetes Dexcom Smart Basal is designed to make basal insulin initiation and management simpler and more personalizedfor users and their healthcare providers.* Dexcom Smart Basal is FDA cleared and now the first and only CGM-integrated basal insulin dosing optimizer for adults aged 18 and older with Type 2 diabetes who are using long-acting insulin.1 SAN DIEGO&#8211;(BUSINESS WIRE)&#8211;DexCom, Inc. (NASDAQ: DXCM), the global leader in glucose biosensing, announced today the FDA has cleared Dexcom Smart Basal, the first and only CGM-integrated basal insulin dosing optimizer designed for adults with Type 2 diabetes on glargine U-100 long-acting insulin therapy.1 Dexcom Smart Basal will &hellip; Continue reading \"Dexcom Smart Basal Receives FDA Clearance Becoming the First and Only CGM-integrated Basal Insulin Dosing Optimizer for Type 2 Diabetes\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/dexcom-smart-basal-receives-fda-clearance-becoming-the-first-and-only-cgm-integrated-basal-insulin-dosing-optimizer-for-type-2-diabetes\/","og_site_name":"Market Newsdesk","article_published_time":"2025-11-19T13:42:02+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20251119356019\/en\/2648806\/4\/Smart_Basal_FDA_Clearance_Image-UI-1.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dexcom-smart-basal-receives-fda-clearance-becoming-the-first-and-only-cgm-integrated-basal-insulin-dosing-optimizer-for-type-2-diabetes\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dexcom-smart-basal-receives-fda-clearance-becoming-the-first-and-only-cgm-integrated-basal-insulin-dosing-optimizer-for-type-2-diabetes\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Dexcom Smart Basal Receives FDA Clearance Becoming the First and Only CGM-integrated Basal Insulin Dosing Optimizer for Type 2 Diabetes","datePublished":"2025-11-19T13:42:02+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dexcom-smart-basal-receives-fda-clearance-becoming-the-first-and-only-cgm-integrated-basal-insulin-dosing-optimizer-for-type-2-diabetes\/"},"wordCount":694,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dexcom-smart-basal-receives-fda-clearance-becoming-the-first-and-only-cgm-integrated-basal-insulin-dosing-optimizer-for-type-2-diabetes\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20251119356019\/en\/2648806\/4\/Smart_Basal_FDA_Clearance_Image-UI-1.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dexcom-smart-basal-receives-fda-clearance-becoming-the-first-and-only-cgm-integrated-basal-insulin-dosing-optimizer-for-type-2-diabetes\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/dexcom-smart-basal-receives-fda-clearance-becoming-the-first-and-only-cgm-integrated-basal-insulin-dosing-optimizer-for-type-2-diabetes\/","name":"Dexcom Smart Basal Receives FDA Clearance Becoming the First and Only CGM-integrated Basal Insulin Dosing Optimizer for Type 2 Diabetes - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dexcom-smart-basal-receives-fda-clearance-becoming-the-first-and-only-cgm-integrated-basal-insulin-dosing-optimizer-for-type-2-diabetes\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dexcom-smart-basal-receives-fda-clearance-becoming-the-first-and-only-cgm-integrated-basal-insulin-dosing-optimizer-for-type-2-diabetes\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20251119356019\/en\/2648806\/4\/Smart_Basal_FDA_Clearance_Image-UI-1.jpg","datePublished":"2025-11-19T13:42:02+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dexcom-smart-basal-receives-fda-clearance-becoming-the-first-and-only-cgm-integrated-basal-insulin-dosing-optimizer-for-type-2-diabetes\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/dexcom-smart-basal-receives-fda-clearance-becoming-the-first-and-only-cgm-integrated-basal-insulin-dosing-optimizer-for-type-2-diabetes\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dexcom-smart-basal-receives-fda-clearance-becoming-the-first-and-only-cgm-integrated-basal-insulin-dosing-optimizer-for-type-2-diabetes\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20251119356019\/en\/2648806\/4\/Smart_Basal_FDA_Clearance_Image-UI-1.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20251119356019\/en\/2648806\/4\/Smart_Basal_FDA_Clearance_Image-UI-1.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dexcom-smart-basal-receives-fda-clearance-becoming-the-first-and-only-cgm-integrated-basal-insulin-dosing-optimizer-for-type-2-diabetes\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Dexcom Smart Basal Receives FDA Clearance Becoming the First and Only CGM-integrated Basal Insulin Dosing Optimizer for Type 2 Diabetes"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/911587","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=911587"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/911587\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=911587"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=911587"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=911587"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}